His lab is working on refining the alanine-scanning assay to a few important residues that can accurately distinguish involving fibrils from neurodegenerative tauopathies. He envisions making use of this streamlined assay for postmortem neuropathological analysis, And perhaps for blood screening of tauopathies.Various colleagues have made the count